Pneumonia vaccine may cut Alzheimer's risk by up to 40%

A new study from Duke University found that receiving the pneumonia vaccine reduces the risk of developing Alzheimer's by 25% to 30% and up to 40% in those without genetic risk factors.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Influenza and pneumococcal vaccination may lower risk for the development of Alzheimer's disease in older adults, two large observational studies suggest.Medscape Medical News
Source: Medscape Med Students Headlines - Category: Universities & Medical Training Tags: Psychiatry News Source Type: news
Two new studies being presented Monday at this summer's virtual Alzheimer's Association International Conference found a lower incidence of Alzheimer's in people who got flu and pneumonia vaccines.
Source: WebMD Health - Category: Consumer Health News Source Type: news
The authors propose that the shots might keep the immune system primed to battle diseases that would otherwise contribute to cognitive decline.
Source: The Scientist - Category: Science Tags: News & Opinion Source Type: news
MONDAY, July 27, 2020 -- Getting vaccinated to protect against pneumonia and flu may offer an unexpected benefit -- a lower risk of Alzheimer's disease, new research suggests. Two new studies being presented Monday at a virtual conference of the...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news
Source: NPR Health and Science - Category: Consumer Health News Authors: Source Type: news
(Alzheimer's Association) Flu (influenza) and pneumonia vaccinations are associated with reduced risk of Alzheimer's disease, according to new research reported at the Alzheimer's Association International Conference ® (AAIC ® ) 2020.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
This study provides direct evidence for the contribution of gut microbiota to the cognitive decline during normal aging and suggests that restoring microbiota homeostasis in the elderly may improve cognitive function. On Nutraceutical Senolytics https://www.fightaging.org/archives/2020/05/on-nutraceutical-senolytics/ Nutraceuticals are compounds derived from foods, usually plants. In principle one can find useful therapies in the natural world, taking the approach of identifying interesting molecules and refining them to a greater potency than naturally occurs in order to produce a usefully large therape...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
In this study, we hypothesized that moderately and chronically reducing ACh could attenuate the deleterious effects of aging on NMJs and skeletal muscles. To test this hypothesis, we analyzed NMJs and muscle fibers from heterozygous transgenic mice with reduced expression of the vesicular ACh transporter (VAChT), VKDHet mice, which present with approximately 30% less synaptic ACh compared to control mice. Because ACh is constitutively decreased in VKDHet, we first analyzed developing NMJs and muscle fibers. We found no obvious morphological or molecular differences between NMJs and muscle fibers of VKDHet and contro...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
James Peyer, formerly of Apollo Ventures and now at the larger Kronos BioVentures, has a range of interesting views on the new and growing longevity biotechnology industry. Apollo Ventures was one of the earlier longevity-focused funds to emerge from the comparatively small community of scientists, patient advocates, and investors enthusiastic to accelerate progress towards the treatment of aging as a medical condition. The presentation here was given earlier this year at the Ending Age-Related Diseases conference organized by the Life Extension Advocacy Foundation. In the matter of creating new medical therapies, t...
Source: Fight Aging! - Category: Research Authors: Tags: Healthy Life Extension Community Source Type: blogs
This study elucidates the potential to use mitochondria from different donors (PAMM) to treat UVR stress and possibly other types of damage or metabolic malfunctions in cells, resulting in not only in-vitro but also ex-vivo applications. Gene Therapy in Mice Alters the Balance of Macrophage Phenotypes to Slow Atherosclerosis Progression https://www.fightaging.org/archives/2019/07/gene-therapy-in-mice-alters-the-balance-of-macrophage-phenotypes-to-slow-atherosclerosis-progression/ Atherosclerosis causes a sizable fraction of all deaths in our species. It is the generation of fatty deposits in blood vessel...
Source: Fight Aging! - Category: Research Authors: Tags: Newsletters Source Type: blogs
More News: Alzheimer's | Genetics | Health | Pneomococcal Vaccine | Pneumonia | Study | Vaccines